The dilemma of reducing treatment for patients with moderate-severe controlled asthma

被引：0
|
作者：
Marin Romero, S. [1 ]
Jara Palomares, L. [1 ,2 ]
机构：
[1] Hosp Univ Virgen Rock, Unidad Med Quirarg Enfermedades Resp, Seville, Spain
[2] Inst Salud Carlos III, CIBERES, Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2020年 / 220卷 / 02期
关键词：
D O I：
10.1016/j.rce.2019.07.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [1] USEFULNESS OF THEOPHYLLINE IN THE TREATMENT OF MODERATE-SEVERE ASTHMA
    RIVAS, PC
    ROCHA, RG
    FERNANDEZ, EB
    SANZ, CC
    GRACIA, FD
    [J]. REVISTA CLINICA ESPANOLA, 1994, 194 (04): : 288 - 290
  • [2] Is a Mobile Application Useful for Patients with Moderate-Severe Asthma?
    Martin, Sonia Herrero
    de Heredia, Javier Hueto Perez
    Remon, Alberto Cuesta
    Fernandez, Marisol Gomez
    Anton, Maria M.
    Cabases, Juan
    Rey, Ruth Garcia
    Rivas, Pilar Cebollero
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 (08): : 556 - 558
  • [3] Treatment of Moderate-severe Asthma: An Alternative Strategy to the Guidelines Recommendations
    Alejro Perez de Llano, Luis
    Gancedo, Santiago Quirce
    Moral, Vicente Plaza
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 (04): : 243 - 245
  • [4] Identifying Baseline Differences in Autonomy in Patients with Moderate-Severe Asthma
    Buckey, Timothy
    Morales, Knashawn
    Apter, Andrea
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB167 - AB167
  • [5] Step-down of moderate-severe asthma treatment in clinical practice
    Mogrovejo Calle, Alexandra Suliana
    Martinez Moragon, Eva
    Delgado Romero, Julio
    Levy Naon, Alberto
    Gonzalez Barcala, Francisco Javier
    Serrano Gutierrez, Virginia
    Moreno Fernandez, Antonio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Analysis of inflammatory cytokines during stable asthma and asthma exacerbations in patients with moderate-severe asthma
    De Boer, Maria G.
    Van Der Ploeg, E. K.
    Dorleijn, M.
    De Bruijn, M.
    Van Nimwegen, M.
    Hendriks, R. W.
    Braunstahl, G.
    Tramper, G.
    [J]. ALLERGY, 2020, 75 : 7 - 7
  • [7] "App" for uncontrolled moderate-severe asthma patients follow-up
    Martin, Sonia Herrero
    de Heredia, Javier Hueto Perez
    Gomez, Marisol
    Remon, Alberto Cuesta
    Lancharro, Francisco Campano
    Urra, Tamara Gutierrez
    Rivas, Pilar Cebollero
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [8] Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
    Yorgancioglu, A. A.
    Pavord, I.
    Brusselle, G.
    Pitrez, P.
    Oosterholt, S.
    Pg, A.
    Della Pasqua, O.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [9] Seven years of clinical experience with omalizumab for moderate-severe allergic asthma treatment
    Morales-Cabeza, C.
    Buendia-Bravo, S.
    Baeza, M. L.
    Rodriguez-Gonzalez, C. G.
    Sanjurjo-Saez, M.
    Zubeldia, J. M.
    [J]. ALLERGY, 2016, 71 : 257 - 257
  • [10] Follow-up of patients with moderate-severe allergic asthma treated with omalizumab
    Larco, J.
    Romero, D.
    Bobolea, I
    Barranco, P.
    Villasante, C.
    Alvarez Sala, R.
    Quirce, S.
    [J]. ALLERGY, 2010, 65 : 530 - 531
12345